Age-standardized highest achieved educational level at enrollment was grouped into low, medium, or high, based on the International Standard Classification of Education
Specialist analysis includes areas such as nutrigenetics, nutrigenomics, metabolomics, microflora, hormones, and pharmacogenomics (prescription medicine)
The enhanced potency and extended dosing interval of semaglutide mark a significant advancement in GLP-1 RA therapy for both glycemic and weight management
A newer drug of this class is semaglutide (sold under the brand name Wegovy), which was approved in 2021 and was found, on average, to reduce weight by 15% in one clinical trial where people took the drug for 68 weeks
Taoka S, Ohja S, Shan X, Kruger WD, and Banerjee R (1998)
Am J Psychiatry (2022) 179(11):82432